Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Anne Phillips

Showing results (41-50 of 156) with videos related to

Pageof 16
Sort By:
Familial Cancer|October 2, 2013
Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancerBettina Meiser, Melanie A Price, Phyllis N Butow, et al.
American Journal of Cancer Research|January 11, 2023
Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholdersWanyuan Cui, Kelly-Anne Phillips, Richard A Anderson, et al.
Breast Cancer Research and Treatment|April 6, 2010
Predictors of breast cancer screening behavior in women with a strong family history of the diseaseMelanie A Price, Phyllis N Butow, Margaret Charles, et al.
Internal Medicine Journal|November 6, 2024
Uptake of gonadotrophin-releasing hormone agonists for prevention of premature ovarian insufficiency in women undergoing chemotherapy: an Australian single-centre studyFelicity C Martin, Kelly-Anne Phillips, Nora Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Prognosis of premenopausal breast cancer and childbirth prior to diagnosisKelly-Anne Phillips, Roger L Milne, Michael L Friedlander, et al.
Springerplus|June 3, 2015
Women's preferences for selective estrogen reuptake modulators: an investigation using the time trade-off techniqueAngelique F Ralph, Brittany Ager, Melanie L Bell, et al.
Cancer|November 2, 2002
HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer RegistryLouise A Quenneville, Kelly-Anne Phillips, Hilmi Ozcelik, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 16, 2023
Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysisMarliese Alexander, Kim Jachno, Kelly-Anne Phillips, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2006
Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancerYoland Antill, John Reynolds, Mary-Anne Young, et al.
Human Genetics|February 26, 2003
Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinicsClare L Scott, Mark A Jenkins, Melissa C Southey, et al.
Pageof 16

Showing results (41-50 of 156) with videos related to

Sort By:
Pageof 16
Familial Cancer|October 2, 2013
Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancerBettina Meiser, Melanie A Price, Phyllis N Butow, et al.
American Journal of Cancer Research|January 11, 2023
Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholdersWanyuan Cui, Kelly-Anne Phillips, Richard A Anderson, et al.
Breast Cancer Research and Treatment|April 6, 2010
Predictors of breast cancer screening behavior in women with a strong family history of the diseaseMelanie A Price, Phyllis N Butow, Margaret Charles, et al.
Internal Medicine Journal|November 6, 2024
Uptake of gonadotrophin-releasing hormone agonists for prevention of premature ovarian insufficiency in women undergoing chemotherapy: an Australian single-centre studyFelicity C Martin, Kelly-Anne Phillips, Nora Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Prognosis of premenopausal breast cancer and childbirth prior to diagnosisKelly-Anne Phillips, Roger L Milne, Michael L Friedlander, et al.
Springerplus|June 3, 2015
Women's preferences for selective estrogen reuptake modulators: an investigation using the time trade-off techniqueAngelique F Ralph, Brittany Ager, Melanie L Bell, et al.
Cancer|November 2, 2002
HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer RegistryLouise A Quenneville, Kelly-Anne Phillips, Hilmi Ozcelik, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 16, 2023
Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysisMarliese Alexander, Kim Jachno, Kelly-Anne Phillips, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2006
Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancerYoland Antill, John Reynolds, Mary-Anne Young, et al.
Human Genetics|February 26, 2003
Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinicsClare L Scott, Mark A Jenkins, Melissa C Southey, et al.
Pageof 16